Abstract
Purpose:
The normally sterile urinary tract is constantly challenged by microbial invasion leading to a high prevalence of isolated, recurrent and catheter associated urinary tract infection. The continuous emergence of bacterial resistance following overuse of traditional antibiotics requires the urgent development of alternative treatment strategies. The involvement of innate immune mechanisms in host defense is an emerging field of microbiological research with recent work focusing on the urinary tract. We performed a comprehensive literature review to establish the current level of knowledge concerning the role of innate immunity and specifically antimicrobial peptides within the human urinary tract.
Materials and Methods:
A systematic review of the literature was performed by searching PubMed® from January 1988 to September 2008. Electronic searches were limited to the English language using the key words antimicrobial, peptide and urinary. Reference lists from relevant reviews were hand searched and appropriate articles were retrieved. The proceedings of conferences held in the last 2 years by the American Urological Association, European Association of Urology and British Association of Urological Surgeons were also searched.
Results:
Several defensive mechanisms have evolved in response to the threat of urinary infection, comprising physical factors and innate immune responses characterized by the expression of antimicrobial peptides. Antimicrobial peptides are small (less than 10 kDa), cationic and amphipathic peptides of variable length, sequence and structure with broad spectrum killing activity against a wide range of microorganisms including gram-positive and gram-negative bacteria. Several antimicrobial peptides have been identified in the urinary tract, and the amount and type of antimicrobial peptides expressed vary according to tissue source and disease state. These differences may reflect altered levels of innate response and, hence, susceptibility to infection. Antimicrobial peptides are already being exploited therapeutically for skin and endovascular catheter infection, and prospects for useful application in the urinary tract are emerging.
Conclusions:
Although investigation of antimicrobial peptide function in the human urinary tract is at an early stage, it is clear that there is considerable potential for the future design of novel therapeutic strategies. More knowledge is needed concerning the pathway of involvement of antimicrobial peptides in the maintenance of urinary tract sterility and the ways in which this is altered during active infection.
References
- 1 : Urinary tract infections: new insights into a common problem. Postgrad Med J2005; 81: 83. Google Scholar
- 2 : Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med2002; 113: 5S. Google Scholar
- 3 : Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol2005; 19: 861. Google Scholar
- 4 : Prevention of recurrent urinary-tract infections in women. Lancet1999; 353: 7. Google Scholar
- 5 : Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med2007; 85: 317. Google Scholar
- 6 : Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry1995; 34: 4393. Google Scholar
- 7 : Membrane pores induced by magainins. Biochemistry1996; 35: 13723. Google Scholar
- 8 : Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta1999; 1462: 55. Google Scholar
- 9 : Peptide-based antibiotics: a potential answer to raging antimicrobial resistance. Drug Dev Res2000; 50: 440. Google Scholar
- 10 : Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry1997; 36: 6124. Google Scholar
- 11 : Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry1998; 37: 11856. Google Scholar
- 12 : In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob Agents Chemother2002; 46: 1059. Google Scholar
- 13 : Interactions of an antimicrobial peptide, magainin-2, with outer and inner membranes of gram-negative bacteria. Biochim Biophys Acta1997; 1327: 119. Google Scholar
- 14 : Amphipathic, alpha-helical antimicrobial peptides. Biopolymers2000; 55: 4. Google Scholar
- 15 : The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol2006; 4: 529. Google Scholar
- 16 : A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis. Nephrol Dial Transplant1997; 12: 2557. Google Scholar
- 17 : Paneth cell defensins: key effector molecules of innate immunity. Biochem Soc Trans2006; 34: 263. Google Scholar
- 18 : Human neutrophil peptides in vaginitis/cervicitis of different etiology. Pol J Microbiol2007; 56: 185. Google Scholar
- 19 : Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol1998; 152: 1247. Google Scholar
- 20 : Differential expression of the HD5 antimicrobial peptide in the human urinary tract. BJU Int2008; 101: 42. Google Scholar
- 21 : Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A2002; 99: 2129. Google Scholar
- 22 : Hepcidin, the recently identified peptide that appears to regulate iron absorption. J Nutr2004; 134: 1. Google Scholar
- 23 : Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest1998; 101: 1633. Google Scholar
- 24 : Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis2002; 2: 20. Google Scholar
- 25 : Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun2002; 70: 3053. Google Scholar
- 26 : Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium. Fertil Steril2003; 79: 856. Google Scholar
- 27 : Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol2003; 59: 1. Google Scholar
- 28 : A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet2006; 79: 439. Google Scholar
- 29 : The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood2000; 96: 3086. Google Scholar
- 30 : The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med2006; 12: 636. Google Scholar
- 31 : Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem2001; 276: 7806. Google Scholar
- 32 : LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett2000; 480: 147. Google Scholar
- 33 : Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood2002; 100: 3776. Google Scholar
- 34 : Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis2003; 42: 658. Google Scholar
- 35 : Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int2004; 65: 791. Google Scholar
- 36 : Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A2006; 103: 1834. Google Scholar
- 37 : Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int2000; 57: 2004. Google Scholar
- 38 : Toll-like receptors in innate immunity. Int Immunol2005; 17: 1. Google Scholar
- 39 : Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta2008; 1778: 357. Google Scholar
- 40 www.migenix.com/prod_226.html. Accessed February 11, 2009. Google Scholar
- 41 : In vitro microbicidal activitites of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis. Antimicrob Agents Chemother2002; 46: 34. Google Scholar
- 42 : Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun2000; 68: 5816. Google Scholar
- 43 : Defending the epithelium. Nat Med2006; 12: 607. Google Scholar
- 44 : Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol2004; 173: 2909. Google Scholar
- 45 : Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut2003; 52: 735. Google Scholar
- 46 : Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25dihydroxyvitamin D3. FASEB J2005; 19: 1067. Google Scholar
- 47 : Regulation of vitamin D-1alpha-hydroxylase in a human cortical collecting duct cell line. Kidney Int2001; 60: 1277. Google Scholar
- 48 : Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A2006; 103: 9178. Google Scholar
- 49 : Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev2008; . CD004013. Google Scholar
Newcastle University, Newcastle upon Tyne, United Kingdom
